| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Fate Therapeutics Inc (NASDAQ: FATE)
FATE Technical Analysis
5
| As on 9th Jun 2023 FATE STOCK Price closed @ 4.87 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 31.38 & Strong Sell for SHORT-TERM with Stoploss of 43.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FATESTOCK Price
| Open | 5.31 | Change | Price | % |
| High | 5.36 | 1 Day | -0.43 | -8.11 |
| Low | 4.82 | 1 Week | -0.26 | -5.07 |
| Close | 4.87 | 1 Month | -1.16 | -19.24 |
| Volume | 2546636 | 1 Year | -53.89 | -91.71 |
| 52 Week High 64.34 | 52 Week Low 4.24 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FATE Daily Charts |
FATE Intraday Charts |
Whats New @ Bazaartrend |
FATE Free Analysis |
|
|
FATE Important Levels Intraday
| RESISTANCE | 5.91 |
| RESISTANCE | 5.58 |
| RESISTANCE | 5.37 |
| RESISTANCE | 5.16 |
| SUPPORT | 4.58 |
| SUPPORT | 4.37 |
| SUPPORT | 4.16 |
| SUPPORT | 3.83 |
FATE Forecast April 2024
| 4th UP Forecast | 49.4 |
| 3rd UP Forecast | 35.12 |
| 2nd UP Forecast | 26.29 |
| 1st UP Forecast | 17.46 |
| 1st DOWN Forecast | -7.72 |
| 2nd DOWN Forecast | -16.55 |
| 3rd DOWN Forecast | -25.38 |
| 4th DOWN Forecast | -39.66 |
FATE Weekly Forecast
| 4th UP Forecast | 23.14 |
| 3rd UP Forecast | 17.28 |
| 2nd UP Forecast | 13.66 |
| 1st UP Forecast | 10.04 |
| 1st DOWN Forecast | -0.30 |
| 2nd DOWN Forecast | -3.92 |
| 3rd DOWN Forecast | -7.54 |
| 4th DOWN Forecast | -13.40 |
FATE Forecast2024
| 4th UP Forecast | 125.38 |
| 3rd UP Forecast | 86.73 |
| 2nd UP Forecast | 62.84 |
| 1st UP Forecast | 38.95 |
| 1st DOWN Forecast | -29.21 |
| 2nd DOWN Forecast | -53.1 |
| 3rd DOWN Forecast | -76.99 |
| 4th DOWN Forecast | -115.64 |
Fate Therapeutics Inc ( NASDAQ USA Symbol : FATE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FATE Business Profile
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors, as well as ProTmune for the treatment of hematologic malignancies and rare genetic disorders. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California. Address: 3535 General Atomics Court, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service